This information was published on 2021-03-01T01:10:12 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2125840 |
| (220) |
05 Oct 2020
|
| (300) |
US, 30 Sep 2020, 90228270
|
| (511) (510) |
Class 5
Pharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions; Pharmaceutical formulations; Antibiotics; Pharmaceutical formulations for treatment of Clostridioides difficile infection |
| (540) | COQUERDI |
| (550) | Word |
| (730) |
Summit Therapeutics Inc.
|
| (750) |
mdp Patent and Trade Mark Attorneys
|
Find out more about publications on the About page.